Martine van Vugt
Director/Board Member bij SCANDION ONCOLOGY A/S
Actieve functies van Martine van Vugt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENMAB A/S | Corporate Officer/Principal | 29-03-2023 | - |
| Human Resources Officer | 01-01-2019 | 29-03-2023 | |
| TME PHARMA N.V. | Director/Board Member | 24-06-2021 | - |
| Independent Dir/Board Member | 24-06-2021 | - | |
| SCANDION ONCOLOGY A/S | Director/Board Member | 01-04-2022 | - |
| Independent Dir/Board Member | 01-04-2022 | - | |
Immagene BV
 Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Director/Board Member | - | - |
| Hollandbio | Director/Board Member | - | - |
Loopbaan van Martine van Vugt
Opleiding van Martine van Vugt
| University of Utrecht | Doctorate Degree |
| Wageningen University | Graduate Degree |
Statistieken
Internationaal
| Nederland | 5 |
| Denemarken | 3 |
| Duitsland | 2 |
Operationeel
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Human Resources Officer | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| GENMAB A/S | Health Technology |
| TME PHARMA N.V. | Health Technology |
| SCANDION ONCOLOGY A/S | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Hollandbio | |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Martine van Vugt
- Ervaring
